Export Licenses Sent to Congress: Business as Usual
Published Date: 9/1/2026
Notice
Summary
The Directorate of Defense Trade Controls and the Department of State give notice that the attached Notifications of Proposed Commercial Export Licenses were submitted to Congress on the dates indicated.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-17655, Passports: Expanding Online Passport Renewal Overseas
The Department proposes to amend 22 CFR 51.21 by consolidating requirements for persons applying by mail and online in the United States and overseas. This proposed change includes expanding online passport application availability to qualified applicants located in foreign countries. In addition, the Department is proposing to remove the requirement that an applicant's most recently issued passport must have a year or less of remaining validity to qualify to submit an online passport application. Finally, the Department is proposing technical corrections to 51.8(b) to change "on-line" to read "online" for consistency.
2026-04931, Schedule of Fees for Consular Services-Fee for Administrative Processing of Request for Certificate of Loss of Nationality of the United States
Good news for U.S. citizens and nationals who want to give up their citizenship! Starting April 13, 2026, the fee for processing a Certificate of Loss of Nationality drops from $2,350 to just $450. This big price cut makes it way easier and cheaper to handle this important paperwork at U.S. embassies and consulates.
2025-17851, Schedule of Fees for Consular Services, Department of State and Overseas Embassies and Consulates-Visa Services Fee Changes
The Department of State is adding a $1 fee to enter the Diversity Visa lottery to share costs more fairly among all applicants. This means everyone who wants to try their luck at the visa lottery will pay a small fee upfront, instead of only winners paying later. The new fee will start when you register online, so get ready to pay a buck when you apply!
2025-14826, Visas: Visa Bond Pilot Program
The Department of State is launching a 12-month pilot program where some travelers applying for B-1/B-2 visas from certain countries might need to pay a bond up to $15,000. This applies to visitors from places with high visa overstays or special citizenship rules. The goal? To make sure folks follow visa rules and keep travel safe and fair.
2026-17748, 30-Day Notice of Proposed Information Collection: Application for Permanent/Temporary Export or Temporary Import of Classified Defense Articles and Classified Technical Data
The Department of State has submitted the information collection described below to the Office of Management and Budget (OMB) for approval. In accordance with the Paperwork Reduction Act of 1995 we are requesting comments on this collection from all interested individuals and organizations. The purpose of this Notice is to allow 30 days for public comment.
2026-17576, International Traffic in Arms Regulations: Extension of Temporary Modification of Category XI(b) of the U.S. Munitions List
The Department of State (the Department), pursuant to its regulations and in the interest of the national security and foreign policy of the United States, extends a previous temporary modification of Category XI(b) of the United States Munitions List (USML).
Previous / Next Documents
Previous: 2026-17812, Determination That NAMENDA (Memantine Hydrochloride) Tablets, 5 Milligrams and 10 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA, Agency, or we) has determined that NAMENDA (memantine hydrochloride) tablets, 5 milligrams (mg) and 10 mg, were not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to these drug products, and it will allow FDA to continue to approve ANDAs that refer to the products as long as the ANDAs meet relevant legal and regulatory requirements.
Next: 2026-17814, Social Security Ruling, SSR 26-2p; Titles II and XVI: Documenting and Evaluating Disability in Young Adults
We are providing notice of SSR 26-2p. This SSR explains our policies and consolidates information from our regulations on documenting and evaluating disability in young adults. This ruling rescinds and replaces SSR 11-2p.